Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Gross Profit (2019 - 2025)

Eton Pharmaceuticals' Gross Profit history spans 7 years, with the latest figure at $7.9 million for Q3 2025.

  • For Q3 2025, Gross Profit rose 24.64% year-over-year to $7.9 million; the TTM value through Sep 2025 reached $36.1 million, up 75.62%, while the annual FY2024 figure was $23.4 million, 11.16% up from the prior year.
  • Gross Profit for Q3 2025 was $7.9 million at Eton Pharmaceuticals, down from $11.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $11.9 million in Q2 2025 and bottomed at $158000.0 in Q3 2021.
  • The 5-year median for Gross Profit is $5.6 million (2024), against an average of $5.7 million.
  • The largest annual shift saw Gross Profit surged 343666.67% in 2021 before it tumbled 87.13% in 2022.
  • A 5-year view of Gross Profit shows it stood at $5.7 million in 2021, then rose by 11.17% to $6.4 million in 2022, then tumbled by 42.92% to $3.6 million in 2023, then surged by 78.4% to $6.5 million in 2024, then rose by 21.29% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Gross Profit are $7.9 million (Q3 2025), $11.9 million (Q2 2025), and $9.9 million (Q1 2025).